A fusion peptide directs enhanced systemic dystrophin exon skipping and functional restoration in dystrophin-deficient mdx mice.

A fusion peptide directs enhanced systemic dystrophin exon skipping and functional restoration in dystrophin-deficient mdx mice.

Duchenne muscular dystrophy (DMD) is caused by mutations in the DMD gene that abolish the synthesis of dystrophin protein. Antisense oligonucleotides (AOs) targeted to trigger excision of an exon bearing a mutant premature stop codon in the DMD transcript have been shown to skip the mutated exon and...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Yin, H, Moulton, H, Betts, C, Seow, Y, Boutilier, J, Iverson, P, Wood, M
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	2009

Παρόμοια τεκμήρια

Functional rescue of dystrophin-deficient mdx mice by a chimeric peptide-PMO
ανά: Yin, H, κ.ά.
Έκδοση: (2010)

Hexose enhances oligonucleotide delivery and exon skipping in dystrophin-deficient mdx mice
ανά: Gang Han, κ.ά.
Έκδοση: (2016-03-01)

Good news for the mdx mouse community: Improved dystrophin restoration after skipping mouse dystrophin exon 23
ανά: Annemieke Aartsma-Rus
Έκδοση: (2022-12-01)

Context dependent effects of chimeric peptide morpholino conjugates contribute to dystrophin exon-skipping efficiency
ανά: Yin, HF, κ.ά.
Έκδοση: (2016)

Cmah-dystrophin deficient mdx mice display an accelerated cardiac phenotype that is improved following peptide-PMO exon skipping treatment
ανά: Betts, C, κ.ά.
Έκδοση: (2018)

Pip5 transduction peptides direct high efficiency oligonucleotide-mediated dystrophin exon skipping in heart and phenotypic correction in mdx mice.
ανά: Yin, H, κ.ά.
Έκδοση: (2011)

Pip5 transduction peptides direct high efficiency oligonucleotide-mediated dystrophin exon skipping in heart and phenotypic correction in mdx mice
ανά: Yin, H, κ.ά.
Έκδοση: (2011)

Context Dependent Effects of Chimeric Peptide Morpholino Conjugates Contribute to Dystrophin Exon-skipping Efficiency
ανά: HaiFang Yin, κ.ά.
Έκδοση: (2020-12-01)

Effective exon skipping and dystrophin restoration by 2'-o-methoxyethyl antisense oligonucleotide in dystrophin-deficient mice.
ανά: Lu Yang, κ.ά.
Έκδοση: (2013-01-01)

Functional amounts of dystrophin produced by skipping the mutated exon in the mdx dystrophic mouse.
ανά: Lu, Q, κ.ά.
Έκδοση: (2003)

In-frame dystrophin following exon 51-skipping improves muscle pathology and function in the exon 52-deficient mdx mouse.
ανά: Aoki, Y, κ.ά.
Έκδοση: (2010)

Nanopolymers improve delivery of exon skipping oligonucleotides and concomitant dystrophin expression in skeletal muscle of <it>mdx </it>mice
ανά: Sirsi Shashank R, κ.ά.
Έκδοση: (2008-04-01)

Use of antisense-mediated exon skipping to generate dystrophin in muscles of the mdx dystrophic mouse
ανά: Lu, Q, κ.ά.
Έκδοση: (2004)

Cell-penetrating peptide-conjugated antisense oligonucleotides restore systemic muscle and cardiac dystrophin expression and function.
ανά: Yin, H, κ.ά.
Έκδοση: (2008)

Peptide Nucleic Acid Promotes Systemic Dystrophin Expression and Functional Rescue in Dystrophin-deficient mdx Mice
ανά: Xianjun Gao, κ.ά.
Έκδοση: (2015-01-01)

Peptide Nucleic Acid Promotes Systemic Dystrophin Expression and Functional Rescue in Dystrophin-Deficient mdx Mice
ανά: Xianjun Gao, κ.ά.
Έκδοση: (2020-12-01)

Exon skipping peptide-pmos for correction of dystrophin in mouse models of duchenne muscular dystrophy
ανά: Betts, C, κ.ά.
Έκδοση: (2014)

Increased neointimal thickening in dystrophin-deficient mdx mice.
ανά: Uwe Rauch, κ.ά.
Έκδοση: (2012-01-01)

Rescue of a dystrophin-like protein by exon skipping normalizes synaptic plasticity in the hippocampus of the mdx mouse
ανά: Glenn Dallérac, κ.ά.
Έκδοση: (2011-09-01)

Targeted Exon Skipping to Correct Exon Duplications in the Dystrophin Gene
ανά: Kane L Greer, κ.ά.
Έκδοση: (2014-01-01)

In vivo restoration of dystrophin expression in mdx mice using intra-muscular and intra-arterial injections of hydrogel microsphere carriers of exon skipping antisense oligonucleotides
ανά: Shani Attias Cohen, κ.ά.
Έκδοση: (2022-09-01)

Rescu of severely affected dystrophin/utrophin deficient mice by morpholino-oligomer mediated exon skipping
ανά: Goyenvalle, A, κ.ά.
Έκδοση: (2010)

Optimization of peptide nucleic acid antisense oligonucleotides for local and systemic dystrophin splice correction in the mdx mouse.
ανά: Yin, H, κ.ά.
Έκδοση: (2010)

Targeted Exon Skipping to Address “Leaky” Mutations in the Dystrophin Gene
ανά: Sue Fletcher, κ.ά.
Έκδοση: (2012-01-01)

Adenine base editing-mediated exon skipping restores dystrophin in humanized Duchenne mouse model
ανά: Jiajia Lin, κ.ά.
Έκδοση: (2024-07-01)

Muscle regeneration in dystrophin-deficient <it>mdx </it>mice studied by gene expression profiling
ανά: van Ommen G-JB, κ.ά.
Έκδοση: (2005-07-01)

Prevention of dystrophic pathology in severely affected dystrophin/utrophin-deficient mice by morpholino-oligomer-mediated exon-skipping.
ανά: Goyenvalle, A, κ.ά.
Έκδοση: (2010)

The proton pump inhibitor lansoprazole improves the skeletal phenotype in dystrophin deficient mdx mice.
ανά: Arpana Sali, κ.ά.
Έκδοση: (2013-01-01)

Extensive and prolonged restoration of dystrophin expression with vivo-morpholino-mediated multiple exon skipping in dystrophic dogs.
ανά: Yokota, T, κ.ά.
Έκδοση: (2012)

Effect of 2-Aminoethoxydiphenyl Borate on the State of Skeletal Muscles in Dystrophin-Deficient mdx Mice
ανά: Mikhail V. Dubinin, κ.ά.
Έκδοση: (2024-12-01)

Systemic Antisense Therapeutics for Dystrophin and Myostatin Exon Splice Modulation Improve Muscle Pathology of Adult mdx Mice
ανά: Ngoc Lu-Nguyen, κ.ά.
Έκδοση: (2017-03-01)

Deletion of Dystrophin In-Frame Exon 5 Leads to a Severe Phenotype: Guidance for Exon Skipping Strategies.
ανά: Zhi Yon Charles Toh, κ.ά.
Έκδοση: (2016-01-01)

Microarray analysis of mdx mice expressing high levels of utrophin: therapeutic implications for dystrophin deficiency.
ανά: Baban, D, κ.ά.
Έκδοση: (2008)

Mitochondrial Dysfunction Is an Early Consequence of Partial or Complete Dystrophin Loss in mdx Mice
ανά: Timothy M. Moore, κ.ά.
Έκδοση: (2020-06-01)

Exon skipping induces uniform dystrophin rescue with dose-dependent restoration of serum miRNA biomarkers and muscle biophysical properties
ανά: Chwalenia, K, κ.ά.
Έκδοση: (2022)

Testing of SHIRPA, a mouse phenotypic assessment protocol, on Dmd(mdx) and Dmd(mdx3cv) dystrophin-deficient mice.
ανά: Rafael, J, κ.ά.
Έκδοση: (2000)

Rescue of severely affected dystrophin/utrophin-deficient mice through scAAV-U7snRNA-mediated exon skipping
ανά: Goyenvalle, A, κ.ά.
Έκδοση: (2012)

Rescue of severely affected dystrophin/utrophin-deficient mice through scAAV-U7snRNA-mediated exon skipping.
ανά: Goyenvalle, A, κ.ά.
Έκδοση: (2012)

Metabolic remodeling agents show beneficial effects in the dystrophin<it>-</it>deficient <it>mdx</it> mouse model
ανά: Jahnke Vanessa E, κ.ά.
Έκδοση: (2012-08-01)

Correction: Functional and Molecular Effects of Arginine Butyrate and Prednisone on Muscle and Heart in the Dystrophin Deficient mdx mice
Έκδοση: (2010-01-01)